newsfilter
← Latest News
GlobeNewswire·

Bionomics Announces Accepted Abstract and Upcoming Poster Presentations at the American College of Neuropsychopharmacology (ACNP) 2022 Annual Meeting

ADELAIDE, Australia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (NASDAQ:BNOX, ASX: BNO)) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators